Introduction {#s1}
============

Mitochondrial outer membrane (MOM) proteins include a diverse set of enzymes, components of protein import machineries, pore forming proteins, as well as proteins mediating mitochondrial fusion, fission, and motility. In addition, the MOM harbours proteins that regulate apoptosis and mitophagy and hence are of central importance for the fate of the organelle and the whole cell. All these MOM proteins are nuclear-encoded and synthesised on cytosolic ribosomes. Therefore, they have to bear appropriate signals that ensure both their correct targeting to the organelle and their ability to acquire different topologies in the lipid bilayer. Despite their well-recognised importance, the diverse molecular mechanisms by which MOM proteins are specifically targeted to the organelle and inserted into their target membrane remain incompletely defined ([@bib13]).

MOM proteins can be divided into several topological groups ([@bib13]). Some of them span the lipid bilayer with one transmembrane segment (TMS), while others transverse the membrane with multiple β-strands or α-helical structures. Depending on their orientation, single-span proteins can be classified into three groups: the first two are signal- or tail-anchored proteins, which face the intermembrane space (IMS) with either the N- or C-terminus, respectively. These proteins typically expose the bulk of the protein to the cytosol and only a very short segment faces the IMS. A third subclass of single-span proteins exposes soluble domains towards both the IMS and the cytosol. Other integral MOM proteins span the bilayer either with several α-helical TMSs or as β-barrel structures. Whereas the import pathway taken by β-barrel precursor proteins has been studied in some detail ([@bib3]; [@bib14]; [@bib38]), much less is known about the factors and the mechanisms that assure the membrane integration of MOM proteins with helical TMSs.

MOM helical multispan proteins follow a unique import pathway in yeast cells ([@bib4]; [@bib28]). Precursors of these proteins are integrated into the membrane in a process where the MOM protein *m*itochondrial *im*port 1 (Mim1) cooperates with the import receptor Tom70 in binding precursor proteins and facilitating their insertion into the lipid bilayer. Interestingly, it appears that neither other subunits of the translocase of the outer membrane (TOM) nor components residing in the mitochondrial IMS are involved in this process. Currently, it is unresolved whether the MIM complex has only a receptor-like function or it acts also as an insertase ([@bib36]). In addition to mediating the membrane integration of multi-span proteins, Mim1 is also involved in the biogenesis of the import receptors Tom20 and Tom70 and therefore the protein is also required for the proper assembly of the TOM complex ([@bib2]; [@bib10]; [@bib17]; [@bib23]; [@bib35]; [@bib37]). Mim1 is known to interact with Mim2, another protein of the MOM that has a crucial role in the biogenesis of α-helical multispan proteins ([@bib10]; [@bib22]). Both proteins form a high-molecular-weight complex (MIM complex). They transverse the MOM once and expose their N-terminal domains to the cytosol whereas their C-terminal regions are facing the IMS ([@bib10]; [@bib18]; [@bib23]; [@bib37]).

Considering their multifaceted functions, it is not surprising that the absence of Mim1 and/or Mim2 results in severe growth retardation and multiple cellular defects like hampered assembly of the TOM complex, alteration in mitochondrial morphology, and accumulation of unprocessed mitochondrial precursor proteins ([@bib10]; [@bib18]; [@bib26]; [@bib31]; [@bib37]). Mim1 and Mim2 are conserved among various fungi but homologues in any other eukaryotes were not identified so far ([@bib10]; [@bib18]; [@bib27]; [@bib37]). This situation raises the question which factor(s) facilitate the membrane integration of helical MOM proteins in non-fungal organisms.

Recently, a first candidate for such a factor was reported in the parasitic protozoan *Trypanosoma brucei*. It was shown that the integral MOM protein, *p*eripheral *a*rchaic *t*ranslocase of the *o*uter *m*embrane 36 (pATOM36), in analogy to the MIM complex, is involved in the assembly and/or membrane insertion of a small subset of MOM proteins including subunits of the main trypanosomal outer membrane protein translocase (ATOM complex) ([@bib6]; [@bib19]). However, in contrast to the MIM complex, pATOM36 is also directly required for the inheritance of the single unit mitochondrial genome of trypanosomes, termed kinetoplast DNA (kDNA). A fraction of the protein localises to the tripartite attachment complex (TAC) ([@bib19]), which connects the kDNA across the two mitochondrial membranes with the basal body of the flagellum ([@bib34]).

Although pATOM36 and Mim1/2 do not share any sequence or topological similarities ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), we wondered whether convergent evolution allowed these unrelated proteins to fulfil similar tasks in the biogenesis of MOM proteins. To address this question, we expressed pATOM36 in yeast cells. Remarkably, introduction of pATOM36 could complement the deletion of *MIM1, MIM2,* or even of both genes. Accordingly, the presence of pATOM36 in the deletion strains could reverse the known alterations resulting from the absence of the MIM complex. Importantly, the reciprocal complementation was also successful and co-expression of Mim1 and Mim2 in *T. brucei* cells ablated for pATOM36 could rescue all phenotypes associated with the MOM protein biogenesis function of pATOM36. Taken together, we present the first reciprocal functional rescue of two evolutionary unrelated mitochondrial biogenesis complexes between eukaryotic supergroups.

Results {#s2}
=======

pATOM36 forms a native-like complex in yeast cells {#s2-1}
--------------------------------------------------

To better understand the functional relation between yeast Mim1/2 and *T. brucei* pATOM36, we wanted to investigate whether the trypanosomal protein can complement the phenotypes observed in yeast cells lacking the MIM complex. To that aim, plasmids encoding for pATOM36 or its C-terminally 3xHA-tagged version (pATOM36-HA), as well as an empty plasmid (Ø) as a control, were transformed into wild type (WT), *mim1Δ*, *mim2Δ* or *mim1Δ*/*mim2Δ* cells. In *T. brucei,* pATOM36 is an integral MOM protein with the C-terminus exposed to the cytosol ([@bib32]). Blue native (BN)-PAGE analysis has shown that the endogenous protein occurs in two groups of protein complexes of unknown composition with molecular weights of approximately 140--250 kDa and larger than 480 kDa ([@bib19]; [@bib32]).

Initially, we verified that pATOM36-HA can be expressed in the aforementioned yeast strains ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Next, we isolated mitochondria from either control or *mim1Δ/mim2Δ* cells harbouring pATOM36-HA. We observed that the C-terminally HA-tagged pATOM36, similar to the yeast import receptor Tom70, is accessible to added proteinase K in isolated mitochondria, whereas the matrix protein Hep1 was protected as would be expected for intact organelles ([Figure 1A](#fig1){ref-type="fig"}). Alkaline extraction of the isolated organelles showed that pATOM36, as Tom70 but unlike the soluble matrix protein Hep1, was detected in the pellet fraction indicating that it is an integral membrane protein ([Figure 1A](#fig1){ref-type="fig"}). Finally, a BN-PAGE analysis demonstrated that pATOM36 expressed in yeast forms complexes of similar size to the 140 and 250 kDa complexes observed in *T. brucei* mitochondria ([Figure 1B](#fig1){ref-type="fig"}). However, the higher molecular weight complex, which likely corresponds to a TAC subcomplex required for kDNA maintenance ([@bib19]), was not detected. In summary, these results suggest that pATOM36 expressed in yeast cells behaves essentially identical to the endogenous protein: it is embedded into the MOM with its C-terminus facing the cytosol and it forms oligomeric complexes of ca. 140--250 kDa.

![pATOM36 forms native-like complexes in the yeast mitochondrial OM.\
(**A**) Mitochondria isolated from WT or *mim1Δ/mim2Δ* cells expressing pATOM36-HA were left intact or lysed with Triton X-100 (TX) before they were subjected to treatment with proteinase K (PK). Alternatively, other samples were subjected to alkaline extraction followed by separation by centrifugation to pellet (P) and supernatant (S) fractions. All samples were analysed by SDS-PAGE followed by immunodecoration with antibodies against the HA-epitope, the OM receptor protein Tom70, or the matrix soluble protein Hep1. (**B**) Mitochondria were isolated from yeast WT cells transformed with an empty plasmid (-) or from WT and *mim1Δ/mim2Δ* (ΔΔ) cells expressing pATOM36-HA (+). Isolated yeast organelles and mitochondria-enriched fraction from *T. brucei* (Tryp.) cells expressing pATOM36-HA were lysed with 1% digitonin. All samples were then subjected to BN-PAGE followed by immunodecoration with an antibody against the HA-tag. pATOM36-containing complexes are indicated with an asterisk.](elife-34488-fig1){#fig1}

pATOM36 can replace the MIM complex in yeast {#s2-2}
--------------------------------------------

We next asked whether pATOM36 can rescue the growth defect on respiratory carbon sources of *mim1Δ* or *mim2Δ* cells. To that aim, plasmids encoding for pATOM36 or its HA-tagged version, as well as *MIM1* or *MIM2* and an empty plasmid (Ø) as a control, were transformed into wild type, *mim1Δ* and *mim2Δ* strains. The growth of the transformed cells was analysed by drop dilution assays on synthetic fermentative glucose-containing (SD-Leu) and respiratory glycerol-containing media (SG-Leu) at three different temperatures (15°C, 30°C and 37°C). Of note, the expression of pATOM36 and its HA-tagged version did not alter the growth of WT cells. Under all the tested conditions, pATOM36 and pATOM36-HA were able to rescue the growth defect caused by the absence of either Mim1 or Mim2 ([Figure 2A](#fig2){ref-type="fig"}). Of note, the rescue capacity of pATOM36 was similar to that of Mim1 or Mim2 in the corresponding deletion strains.

![pATOM36 rescues the growth defects of cells lacking Mim1, Mim2 or both.\
(**A**) The indicated strains transformed with an empty plasmid (Ø) or with a plasmid expressing pATOM36 or its HA-tagged variant were tested at three different temperatures by drop-dilution assay for growth on synthetic medium containing either glucose (SD-Leu) or glycerol (SG-Leu). For comparison, plasmid-encoded Mim1 or Mim2 were transformed into *mim1Δ* or *mim2Δ* cells, respectively. All dilutions are in fivefold increment. (**B**) Cells deleted for both *MIM1* and *MIM2* (*mim1Δ/mim2Δ*) were transformed with the empty plasmid (Ø) or a plasmid encoding either native pATOM36 or pATOM36-HA. Transformed cells were analysed by drop-dilution assay at the indicated temperatures on synthetic medium containing either glucose (SD-Leu) or glycerol (SG-Leu). All dilutions are in fivefold increment.](elife-34488-fig2){#fig2}

These results suggest that pATOM36 is active in yeast cells but it remained unclear whether pATOM36 can function alone or if it requires one of the remaining Mim proteins. To address this question, we monitored the capacity of pATOM36 to rescue the growth retardation of the double deletion *mim1Δ*/*mim2Δ* cells. We observed that pATOM36 could functionally compensate for the absence of both Mim1 and Mim2, since it was able to rescue the growth defect on non-fermentable carbon sources, a condition which requires fully functional mitochondria ([Figure 2B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

The absence of Mim1 and/or Mim2 in yeast cells results in a variety of mitochondrial defects including reduction in the steady-state levels of Mim1/2 substrates like the outer membrane proteins Ugo1, Tom20 and Tom70 ([@bib10]; [@bib18]; [@bib31]; [@bib37]). We therefore monitored whether expression of pATOM36 restores the reduced levels of these MIM substrates. To that aim we isolated mitochondria from WT and *mim1Δ*/*mim2Δ* cells transformed with either an empty plasmid or a plasmid encoding pATOM36-HA and monitored the levels of the proteins by immunodecoration. The results indicate that, whereas expression of pATOM36-HA in WT cells did not alter the abundance of the tested proteins or did it only to a minor extent, it did restore the levels of Mim1/2 substrates Tom20 and Tom70 in mitochondria from the double deletion cells ([Figure 3A and B](#fig3){ref-type="fig"}). Interestingly, the effect of pATOM36 on the levels of Ugo1 was only marginal, suggesting that pATOM36 has preferences to certain MIM substrates.

![pATOM36 can compensate for the reduced steady state levels and assembly defects in cells lacking both Mim1 and Mim2.\
(**A**) Mitochondria were isolated from WT or *mim1Δ/mim2Δ* cells transformed with either an empty plasmid (-) or with a plasmid encoding pATOM36-HA (+). The specified amounts were analysed by SDS-PAGE and immunodecoration with antibodies against either the indicated mitochondrial proteins or the HA-tag. (**B**) The intensity of the bands from three independent experiments such as those presented in (**A**) was monitored. The amounts of Tom70, Ugo1 and Tom20 in the various mitochondria samples are presented as mean percentage of their levels in control organelles (WT+ Ø). The levels of Fis1 were taken as loading control. Error bars represent ± SD. \*\*p≤0.005, \*\*\*p≤0.0005. (**C**) Whole cell lysates were obtained from WT, *mim1Δ (1Δ), mim2Δ (2Δ),* or the double deletion *mim1Δ/mim2Δ (ΔΔ)* cells transformed with either an empty plasmid (Ø) or with a plasmid encoding pATOM36-HA. Samples were analysed by SDS-PAGE and immunodecoration with antibodies against the indicated mitochondrial proteins. The precursor form of mitochondrial Hsp60 is indicated with an arrowhead. (**D**) The mitochondria described in (**A**) were solubilised in a buffer containing 1% digitonin and then analysed by BN-PAGE followed by western blotting. The membranes were immunodecorated with antibodies against the TOM subunits, Tom40 (long and short exposures) and Tom22. The TOM complex is signposted. A Tom40-containing low molecular weight complex is indicated with an arrowhead. (**E**) Mim1 and pATOM36 interact directly with Tom70. Radiolabelled Mim1 or pATOM36 (input, **I**) were incubated with glutathione beads (-) or with beads that were pre-bound to recombinant GST alone or to GST fused to the cytosolic domain of Tom70 (GST-Tom70). After washing, bound material was eluated and proteins were analysed by SDS--PAGE followed by blotting onto a membrane, and detection with either autoradiography (upper panel) or Ponceau staining (lower panel).\
10.7554/eLife.34488.009Figure 3---source data 1.pATOM36 can compensate for the reduced steady state levels in cells lacking both Mim1 and Mim2.Orinigal data used for quantification in [Figure 3B](#fig3){ref-type="fig"}.](elife-34488-fig3){#fig3}

A further phenotype of cells lacking Mim1/2 is the accumulation of mitochondrial precursor proteins due to hampered assembly of the TOM complex ([@bib18]; [@bib26]; [@bib37]). To test whether pATOM36 is able to reverse this situation, we obtained whole cell lysates from the cells described above. As can be seen in [Figure 3C](#fig3){ref-type="fig"}, the presence of pATOM36-HA in the deletion strains completely eliminated the appearance of the precursor form of mitochondrial Hsp60. The presence of pATOM36-HA in the deletion cell lines resulted also in enhanced levels of Tom40 whereas the amounts of aconitase (Aco1) were not affected ([Figure 3C](#fig3){ref-type="fig"}).

These results suggest that the function of the MIM complex in TOM complex assembly can be replaced by pATOM36. To substantiate this assumption, we used digitonin-solubilised mitochondria, which were isolated from control and deletion strains, and analysed them by BN-PAGE. To detect the TOM complex, the corresponding immunoblots were probed with antibodies against either Tom40 or Tom22. Of note, pATOM36-HA did not affect the assembly of the TOM complex in WT cells ([Figure 3D](#fig3){ref-type="fig"}). As expected, in the absence of Mim1/2, a dramatic reduction in the amount of assembled TOM complex and an appearance of an unassembled Tom40-containing species can be observed. Strikingly, these alterations completely disappeared upon the introduction of pATOM36-HA into these cells ([Figure 3D](#fig3){ref-type="fig"}).

To investigate the specificity of the complementation by pATOM36, we asked whether it can functionally replace another import factor that mediates the biogenesis of other MOM proteins. To that goal, pATOM36 was introduced into cells lacking Mas37/Sam37, a subunit of the TOB/SAM complex that facilitates membrane integration of β-barrel proteins and the TOM subunit Tom22 ([@bib8]; [@bib12]; [@bib39]). [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} shows that pATOM36 could revert neither the drop in the steady-state levels of the TOB complex and its altered assembly behaviour nor the reduced levels of either the β-barrel proteins Tom40 and Porin or the single-span protein Tom22. Thus, the effect of pATOM36 is specific for MIM substrates. These findings further support the notion that the single-span protein Tom22 follows an import pathway that is distinct from that taken by the signal-anchored subunits Tom20 and Tom70.

Previous reports suggested that Tom70 works together with Mim1 in the biogenesis of multi-span helical MOM proteins ([@bib4]; [@bib28]). To test whether pATOM36 can also interact with Tom70, we utilised a recombinant protein composed of the cytosolic domain of Tom70 fused to GST moiety (GST-Tom70). When this protein was incubated with newly synthesised radiolabelled pATOM36, or with Mim1 as a control, we observed a specific binding to both proteins ([Figure 3E](#fig3){ref-type="fig"}). Although we cannot exclude the possibility that Tom70, as an import receptor for MOM proteins, recognises Mim1 and pATOM36 as substrates, it can be envisaged that, similarly to Mim1, pATOM36 can also cooperate with Tom70 in the biogenesis of MOM proteins.

The aforementioned results indicate that pATOM36 can compensate for the loss of the MIM machinery. To demonstrate directly a role of pATOM36 in protein import into the outer membrane of yeast mitochondria, we performed in vitro import assays. To that aim, we tested whether the presence of pATOM36 in mitochondria lacking the MIM complex can rescue the reduced import capacity of the MIM substrates Tom20 and Ugo1 observed for these organelles. To monitor the import efficiency of radiolabelled Tom20 into isolated organelles, we employed an established assay based on the formation of a proteolytic fragment of an N-terminally extended variant of Tom20 ([@bib1]). This assay clearly demonstrated that the presence of pATOM36 is sufficient to improve dramatically the capacity of organelles lacking Mim1/2 to import radiolabelled Tom20 molecules ([Figure 4A](#fig4){ref-type="fig"}). Along the same line, the assembly of newly synthesised Tom20 molecules into pre-existing TOM complexes was markedly improved when pATOM36 was present in mitochondria lacking the MIM complex ([Figure 4B](#fig4){ref-type="fig"}). Similarly to its minor effect on the steady state levels of Ugo1, the presence of pATOM36 did not improve the capacity of isolated mitochondria to import radiolabelled Ugo1 ([Figure 4C](#fig4){ref-type="fig"}). As a control, we checked the effect of pATOM36 on the import of proteins that are not known as MIM substrates like the matrix-targeted model protein pSu9-DHFR or the MOM tail-anchored protein Fis1. In both cases, we did not observe altered import upon expression of pATOM36 ([Figure 4D and E](#fig4){ref-type="fig"}). Collectively, pATOM36 can support the biogenesis of MIM substrates but appears to have preferences to certain ones.

![pATOM36 can rescue some of the import defects of cells lacking the MIM complex.\
(**A**) Mitochondria were isolated from WT cells transformed with an empty plasmid (WT-) or from *mim1Δ/mim2Δ* cells transformed with either an empty plasmid (*-*) or with a plasmid encoding pATOM36-HA (*+*). Radiolabelled Tom20~ext~ molecules (5% input, **I**) were incubated with the indicated isolated organelles for the specified time periods. Then, mitochondria were treated with PK and analysed by SDS-PAGE and autoradiography. A proteolytic fragment of Tom20~ext~, which reflects correct membrane integration, is indicated by an arrowhead. (**B**) Radiolabelled Tom20 was incubated with isolated mitochondria as in (**A**). At the end of the import reactions, mitochondria were solubilised with 0.2% digitonin and samples were analysed by BN-PAGE followed by autoradiography. The migration of Tom20 molecules assembled into the TOM complex is indicated. (**C**) Radiolabelled Ugo1 was incubated with isolated mitochondria as in (**A**). Then, mitochondria were treated with trypsin and analysed by SDS-PAGE and autoradiography. A proteolytic fragment of Ugo1, which reflects correct membrane integration, is indicated by an arrowhead. (**D**) Radiolabelled Fis1-TMC (5% input, I) was incubated with isolated mitochondria as in (**A**). Then, mitochondria were subjected to an IASD assay, re-isolated and analysed by SDS-PAGE and autoradiography. Bands representing correctly integrated Fis1-TMC are marked by an arrowhead. (**E**) Radiolabelled pSu9-DHFR (5% input, I) was incubated with isolated mitochondria as in (**A**). Then, mitochondria were re-isolated and analysed by SDS-PAGE and autoradiography. The precursor and mature forms are indicated by p and m, respectively.](elife-34488-fig4){#fig4}

Finally, we tested whether the trypanosomal protein is able to rescue the mitochondrial fragmentation that is observed in cells lacking Mim proteins. To that goal, we transformed a plasmid encoding pATOM36 into WT, *mim1Δ, mim2Δ,* or *mim1Δ*/*mim2Δ* cells expressing mitochondrial targeted GFP (mito-GFP). Analysis of mitochondria from the resulting cell lines by fluorescence microscopy revealed that pATOM36 is able to revert the mitochondrial fragmentation observed in cells lacking Mim1 and/or Mim2 to the tubular-like morphology of organelles in control cells ([Figure 5A and B](#fig5){ref-type="fig"}).

![*mim1Δ* and *mim2Δ* cells expressing pATOM36 do not show altered mitochondrial morphology.\
(**A**) WT, *mim1Δ, mim2Δ,* and *mim1Δ/mim2Δ* cells harbouring mitochondria-targeted GFP (mito-GFP) were transformed with either an empty plasmid (Ø) as a control (left panels) or a plasmid encoding pATOM36 (right panels). Cells were analysed by fluorescence microscopy and representative images of the predominant morphology for each strain are shown. Scale bar, 5 µm. (**B**) Statistical analysis of the cells described in (**A**). Average values with standard deviation bars of three independent experiments with at least n = 100 cells in each experiment are shown.\
10.7554/eLife.34488.012Figure 5---source data 1.*mim1Δ* and *mim2Δ* cells expressing pATOM36 have normal mitochondrial morphologyOriginal data used for quantification in [Figure 5B](#fig5){ref-type="fig"}.](elife-34488-fig5){#fig5}

Mim1/2 form a native-like MIM complex in trypanosomes {#s2-3}
-----------------------------------------------------

Observing the rescue capacity of pATOM36 in yeast cells, we asked whether the functional similarity between Mim1/2 and pATOM36 allows the yeast proteins to replace the function pATOM36 has in the biogenesis of trypanosomal MOM proteins. To that end, we constructed a plasmid for the co-expression of myc-tagged Mim1 and HA-tagged Mim2 in *T. brucei* ([Figure 6A](#fig6){ref-type="fig"}). Next, this plasmid was introduced into a cell line allowing controlled ablation of pATOM36. In these cells, addition of tetracycline simultaneously initiates the RNAi-mediated degradation of the pATOM36 mRNA as well as the expression of the tagged Mim1 and Mim2.

![Yeast Mim1 and Mim2 form a high-molecular-weight complex in mitochondria of *T.*\
*brucei*. (**A**) Schematic representation of the insert of the pLew100-based vector that allows tetracycline-inducible expression of C-terminally myc-tagged Mim1 and HA-tagged Mim2 in *T. brucei*. Pro prom, procyclin promotor; tet, tetracycline operator; pro sas, procycline splice acceptor site; tub igr, α- and β-tubulin intergenic region; ald polyA, 3\'-UTR of the aldolase gene. (**B**) Top panels: immunoblot analysis of whole cells (Tot), soluble (Cyt) and digitonin-extracted mitochondria-enriched pellet (Mit) fractions of a tetracycline-inducible pATOM36-RNAi cell line expressing Mim1-myc and Mim2-HA. Duplicate blots were analysed for the expression of Mim1-myc (left panels) and Mim2-HA (right panels). ATOM40 and EF1a serve as mitochondrial and cytosolic markers, respectively. Bottom panels: Alkaline extraction of the mitochondria-enriched fraction (Mit) shown in the top panels. The pellet (**P**) and the supernatant (**S**) fractions corresponding to integral membrane and soluble proteins, respectively, were analysed by SDS-PAGE and immunodecoration. ATOM40 and CytC serve as markers for integral and peripheral membrane proteins, respectively. (**C**) Mitochondria-enriched fractions of the same cell line describe in (**B**) were left intact or lysed with Triton X-100 (TX) before they were subjected to treatment with proteinase K (PK). All samples were analysed by SDS-PAGE followed by immunodecoration with antibodies against myc and HA tags, the OM protein ATOM69, the IMS protein TbTim9, or the matrix protein mtHsp70. Note that mtHsp70 contains a folded core, which is protease resistant. A proteolytic fragment of Mim1 and Mim2 is indicated with an arrowhead. (**D**) Duplicate immunoblots from BN-PAGE analysis of mitochondria-enriched fractions of the same cell line describe in (**B**) were probed for Mim1-myc (left panels) and Mim2-HA (right panels). Sections of the coomassie-stained gels serve as loading control. (**E**) Immunoblots of a BN-PAGE analysis of mitochondria-enriched fractions of the *T. brucei* (*T.b*.) cell line simultaneously expressing myc-tagged Mim1 (Mim1-myc) and HA-tagged Mim2 (Mim2-HA) and isolated yeast (*S.c*.) mitochondria simultaneously expressing HA-tagged versions of Mim1 and Mim2. The immunoblots are probed with antibodies against HA- or myc-tag.](elife-34488-fig6){#fig6}

Subcellular fractionation of induced cells showed that both proteins are expressed and, like the mitochondrial marker protein ATOM40, they are exclusively localised in the mitochondrial fraction ([Figure 6B](#fig6){ref-type="fig"}, top panels). Alkaline extraction of the latter revealed that, as the endogenous proteins in yeast, both Mim1 and Mim2 are recovered in the pellet, together with the integral membrane protein ATOM40, whereas the soluble protein CytC was present in the supernatant ([Figure 6B](#fig6){ref-type="fig"}, lower panels). To monitor whether Mim1 and Mim2 are inserted into the membrane in their native orientation, mitochondria-enriched fractions were treated with proteinase K. This treatment resulted for both proteins in the formation of protease-resistant C-terminal fragments ([Figure 6C](#fig6){ref-type="fig"}). Thus, Mim1 and Mim2 acquired their native topology in *T. brucei* mitochondria with their N-terminus exposed to the cytosol and the C-terminus located in the IMS. Mim1 and Mim2 of yeast cells form a complex of approx. 200 kDa ([@bib10]; [@bib18]; [@bib37]). BN-PAGE shows that similar complexes of ca. 230 kDa, which contain both Mim1-myc and Mim2-HA, could be detected in *T. brucei* ([Figure 6D](#fig6){ref-type="fig"}). Importantly, these complexes migrated similarly to complexes harbouring Mim1-HA and Mim2-HA of yeast mitochondria ([Figure 6E](#fig6){ref-type="fig"}). The slightly higher molecular weight than that observed for native complexes in yeast can be explained by the fact that both proteins are tagged. Thus, expression of Mim1 and Mim2 results in a native-like MIM complex in mitochondria from *T. brucei*.

The MIM complex can replace the protein biogenesis function of pATOM36 in *T. brucei* {#s2-4}
-------------------------------------------------------------------------------------

The next question we addressed was whether the MIM complex can take over the function of pATOM36. Ablation of pATOM36 has been shown to cause a growth arrest. Due to its dual function the lack of pATOM36 does not only interfere with the assembly and/or insertion of MOM proteins but it also prevents assembly of the TAC, which causes loss of the kDNA ([Figure 7A](#fig7){ref-type="fig"}) ([@bib19]). Interestingly, introducing Mim1/2 into the pATOM36-depleted cells could not prevent the loss of kDNA but it did cause a milder growth phenotype ([Figure 7A](#fig7){ref-type="fig"}). When mitochondrial proteins from pATOM36-depleted cells expressing Mim1/2 were analysed, we observed that the steady-state levels of the ATOM complex subunits ATOM46, ATOM19, and ATOM14, all of which are greatly reduced in the absence of pATOM36, were restored ([Figure 7B](#fig7){ref-type="fig"}) ([@bib19]). Furthermore, not only the abundance of the ATOM subunits was back to normal levels, but also the subunits were incorporated into the high-molecular-weight ATOM complexes. Of note, in the cell lines complemented by the MIM complex the ATOM subunit complexes were shifted to a slightly higher molecular weight ([Figure 8A](#fig8){ref-type="fig"}). Moreover, complementation of the ATOM40-containing complexes was somewhat incomplete, since the 200 kDa ATOM40 complexes that accumulate after ablation of pATOM36 were still visible ([Figure 8A](#fig8){ref-type="fig"}).

![Yeast Mim1 and Mim2 complement the mitochondrial OM biogenesis phenotype of *T.*\
*brucei* cells ablated for pATOM36. (**A**) Left panel: growth in the presence and absence of tetracycline (black and grey lines, respectively) and loss of kDNA (red line) in the presence of tetracycline of the pATOM36-RNAi parent cell line. Right panel: as in the left but the analysis was done for the pATOM36-RNAi cell line that co-expresses Mim1-myc and Mim2-HA. (**B**) Whole cell lysates from the cell lines as in (**A**) were obtained after the indicated time of induction. Proteins of these samples were analysed by SDS-PAGE and immunodecoration with the indicated antibodies. ATOM46, ATOM19 and ATOM14 are subunits of the ATOM complex. Cytosolic EF1a serves as a loading control.](elife-34488-fig7){#fig7}

![Mim1 and Mim2 rescue the assembly defect of the ATOM complex and the altered mitochondrial morphology in cells lacking pATOM36.\
(**A**) Mitochondria-enriched fractions from the cell lines as in [Figure 7A](#fig7){ref-type="fig"} were obtained after the indicated time of induction. Samples were analysed by BN-PAGE followed by immunodecoration with antibodies against the indicated subunits of the ATOM complex. The migration of the ATOM complex is signposted. Sections of the coomassie-stained gels serve as loading controls. Arrowhead indicates an ATOM40-containing lower molecular weight complex. (**B**) Left images: Immunofluorescence analyses of mitochondrial morphology in the pATOM36 RNAi cell line after 0 or 3 days of induction. Right images: as in the left panels but the analysis was performed with the RNAi cell line co-expressing Mim1-myc and Mim2-HA. ATOM40 is shown in green and DAPI-stained DNA is shown in blue. DIC, differential interference contrast. Scale bar, 5 µm.](elife-34488-fig8){#fig8}

It has previously been described that ablation of pATOM36 in trypanosomes, reminiscent to deletion of the MIM complex in yeast, causes a condensation of the network-like structure of the trypanosomal mitochondrion ([@bib6]) ([Figure 8B](#fig8){ref-type="fig"}, left panel). The immunofluorescence analysis in the right panel of [Figure 8B](#fig8){ref-type="fig"} indicates that in the presence of the MIM complex also this phenotype is reversed and the wild type morphology of the mitochondrion is fully restored. Hence, similarly to the rescue capacity of pATOM36 in yeast cells, Mim1/2 can replace the function of endogenous pATOM36 in MOM protein biogenesis in trypanosomes.

Complementing the biogenesis function of pATOM36 requires both Mim1 and Mim2 {#s2-5}
----------------------------------------------------------------------------

When we transfected the *T. brucei* pATOM36-RNAi cell line with distinct plasmids encoding myc-tagged Mim1 and HA-tagged Mim2 we obtained also clones that mainly expressed either Mim1-myc or Mim2-HA while the other Mim subunit was expressed only in residual amounts ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). In the cell line that mainly expresses Mim1-myc, the protein is found in a complex of approximately 440 kDa ([Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}, middle panel), whereas in the cell line preferentially expressing Mim2-HA this protein is present in a complex of approximately 230 kDa ([Figure 8---figure supplement 1B](#fig8s1){ref-type="fig"}, bottom panel). These complexes are of either higher (Mim1-myc) or similar molecular weights (Mim2-HA) to the one that is formed when both proteins are expressed in similar amounts ([Figure 6D and E](#fig6){ref-type="fig"}). Most importantly, both cell lines show a strong deficiency of ATOM complex assembly ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}, top panels) and a growth arrest ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}, bottom graphs) that are indistinguishable from the parent pATOM36-RNAi cell line ([Figure 8A](#fig8){ref-type="fig"}, left panels and [Figure 7](#fig7){ref-type="fig"}, left graph, respectively). This indicates that expression of Mim1 or Mim2 alone cannot complement for the protein biogenesis phenotype caused by the lack of pATOM36. Furthermore, these results suggest that successful complementation requires similar amounts of Mim1 and Mim2.

Discussion {#s3}
==========

Our study shows that the MIM complex of yeast, consisting of Mim1 and Mim2, and trypanosomal pATOM36 have identical functions, even though they do not share sequence similarity, the same membrane topology, or a similar size ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). This conclusion is based on the stringent criteria that the two proteins can replace each other in reciprocal complementation experiments. The only major limitation is that the role of pATOM36 in mitochondrial DNA inheritance in trypanosomes cannot be carried out by the MIM complex, which is expected since unlike the MIM complex pATOM36 has a dual function ([@bib19]).

The reciprocal complementation is surprising because yeast belongs to the eukaryotic supergroup of the Opisthokonts whereas trypanosomes are Excavates ([@bib7]). Thus, except for being eukaryotes the two systems are essentially unrelated. The most parsimonious explanation for the observed phylogenetic distribution of the two functional analogues is that the MIM complex and pATOM36 evolved after the eukaryotic supergroups were already established. Moreover, the observation that within the Opisthokonts the MIM complex is restricted to fungi suggests that it evolved only after the divergence of the ancestors of fungi and metazoans. Thus, the last eukaryotic common ancestor (LECA) likely did not contain the MIM complex, pATOM36 or any other functional analogue of these proteins. This assumption is in line with the notion that LECA had a much simpler MOM protein import system consisting possibly only of a Tom40-like β-barrel protein ([@bib11]; [@bib25]), whose integration into the MOM is mediated by the TOB/SAM complex, the core subunit of which, Tob55/Sam50, is conserved in all eukaryotes ([@bib11]; [@bib15]; [@bib21]; [@bib30]). During evolution, additional subunits that are anchored in the membrane by α-helices joined the TOM complex to increase its specificity and efficiency. This scenario is supported by the fact that the TOM complexes of yeast, plants and trypanosomes, representatives of three different eukaryotic supergroups, contain three distinct evolutionary unrelated pairs of protein import receptors ([@bib24]; [@bib25]). The appearance of the new TOM subunits required the evolution of a system, such as the MIM complex or pATOM36, that facilitates their assembly with Tom40.

Interestingly, the capacity of pATOM36 expressed in yeast cells to support the biogenesis of MIM substrates is variable with the import receptor Tom20 as the most favourable substrate and the fusion-modulator Ugo1 as the least favourable one. Ugo1 is a carrier-like protein with several TMSs that lack clear homologues in higher eukaryotes. Hence, one can speculate that pATOM36 cannot deal with it well since there are no similar substrates in the MOM of *T. brucei*.

Both Mim1 and Mim2 as well as pATOM36 occur in protein complexes of unknown composition. The successful complementation experiments together with the fact that they form complexes of similar sizes when expressed in the heterologous systems strongly suggest that these complexes do not contain any additional proteins. Their ability for reciprocal rescue also suggests that their essential function does not require any further proteins since it is very unlikely that such factors would be present in the other species.

It is established that pATOM36 and Mim1/Mim2 are integral MOM proteins. However, whereas Mim1 and Mim2 have each a single TMS with the N-terminus facing the cytosol, the topology of pATOM36 is largely unknown ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). It has been demonstrated by antibody shift experiments that the C-terminus of pATOM36 is exposed to the cytosol ([@bib32]), but depending on the prediction programs the protein is postulated to have either one, two or even three TMSs ([@bib19]). While Mim1/Mim2 and pATOM36 do not share sequence similarity and also have different molecular weights (Mim1, 13 kDa; Mim2, 11 kDa; pATOM36, 36 kDa), they all have GxxxG(A) motifs within their putative TMSs ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), which is in line with their oligomeric quaternary structures. It has recently been shown by electrophysiological experiments that Mim1, on its own or in complex with Mim2, can form a cation-selective channel ([@bib22]). Should this channel activity of Mim1 be functionally relevant, we would expect pATOM36 to form also a pore.

Presently, it is unclear whether the convergent evolution of the MIM complex and pATOM36 demonstrated in the present study, resulted in a similar 3D-structure of the two oligomers. Should this be the case, the two complexes may independently have evolved the same mechanisms to perform the equivalent functions. Alternatively, it cannot be excluded that they use structurally different solutions resulting in different mechanisms that nevertheless allow them to carry out the same functions.

There is evidence that both the yeast MIM complex as well as trypanosomal pATOM36 mediate assembly of already integrated MOM proteins and at least for some substrates also the insertion process itself ([@bib2]; [@bib4]; [@bib6]; [@bib10]; [@bib17]; [@bib19]; [@bib23]; [@bib28]; [@bib35]; [@bib37]). Whether the two oligomers directly catalyse protein insertion or whether they form microdomains in the MOM that facilitate membrane integration of helical segments is unclear. In any case, we hypothesise that the MIM complex and pATOM36 should behave similarly in this respect.

The successful complementation of the functions of the yeast MIM complex by trypanosomal pATOM36 and vice versa opens the way for future comparative studies to define the fundamental features the two biogenesis complexes share. The constraints imposed by their identical functions will help to reveal their mechanism of action. Taken together, our work offers new insights into the evolution of mitochondrial import factors and sheds new light on basic aspects of the biogenesis of mitochondrial outer membrane proteins.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                            Designation                                                                                                                       Source or reference             Identifiers                  Additional information
  (species) or\                                                                                                                                                                                                                                           
  resource                                                                                                                                                                                                                                                
  -------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ---------------------------- ----------------------------------------------------------------------------------------------------------------------------
  Strain, strain background (*Saccharomyces cerevisiae*)   WT; W303α; MATα leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15                                                               NA                                                           

  Strain, strain background (*S. cerevisiae*)              *mim1Δ*; W303α; MATα leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 MIM1::KanMX                                              DOI: 10.1242/jcs.103804                                      

  Strain, strain background (*S. cerevisiae*)              *mim2Δ*; W303α; MATα leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 MIM2::HIS3                                               DOI: 10.1242/jcs.103804                                      

  Strain, strain background (*S. cerevisiae*)              *mim1*Δ *mim2Δ*; W303α; MATα leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 MIM1::KanMX MIM2::HIS3                           DOI: 10.1242/jcs.103804                                      

  Strain, strain background (*S. cerevisiae*)              WT; YPH499; MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3-Δ200 leu2-Δ1                                                                                                              

  Strain, strain background (*S. cerevisiae*)              *mas37Δ*; YPH499; MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3-Δ200 leu2-Δ1 MAS37::HIS3                               DOI: 10.1074/jbc.M411510200                                  

  Cell line (*Trypanosoma brucei*)                         29--13, procyclic, pATOM36 RNAi                                                                                                   PMID: 22787278                                               

  Transfected construct (*S. cerevisiae*)                  pATOM36 RNAi + mim1-myc/mim2-HA ([Figures 6](#fig6){ref-type="fig"}, [7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"})   this paper                                                   see Materials and methods

  Transfected constructs (*S. cerevisiae*)                 pATOM36 RNAi + mim1-myc/mim2-HA ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"})                                       this paper                                                   see Materials and methods

  Antibody                                                 anti-HA (polyclonal rat)                                                                                                          Roche                           11867423001; AB_390918       WB 1:15000

  Antibody                                                 anti-Tom70 (polyclonal rabbit)                                                                                                    N/A                                                          WB 1:2000

  Antibody                                                 anti-Hep1 (polyclonal rabbit)                                                                                                     N/A                                                          WB 1:3000

  Antibody                                                 anti-Ugo1 (polyclonal rabbit)                                                                                                     N/A                                                          WB 1:500

  Antibody                                                 anti-Tom20 (polyclonal rabbit)                                                                                                    N/A                                                          WB 1:1600

  Antibody                                                 anti-Fis1 (polyclonal rabbit)                                                                                                     N/A                                                          WB 1:1000

  Antibody                                                 anti-Hsp60 (polyclonal rabbit)                                                                                                    N/A                                                          WB 1:100000

  Antibody                                                 anti-Tom40 (polyclonal rabbit)                                                                                                    N/A                                                          WB 1:4000

  Antibody                                                 anti-Aco1 (polyclonal rabbit)                                                                                                     N/A                                                          WB 1:7000

  Antibody                                                 anti-Tom22 (polyclonal rabbit)                                                                                                    N/A                                                          WB 1:2000

  Antibody                                                 anti-Tob55 (polyclonal rabbit)                                                                                                    N/A                                                          WB 1:2000

  Antibody                                                 anti-Por1 (polyclonal rabbit)                                                                                                     N/A                                                          WB 1:4000

  Antibody                                                 anti-rat (HRP coupled goat)                                                                                                       Abcam                           ab6845; AB_955449            WB 1:3000

  Antibody                                                 anti-rabbit (HRP coupled goat)                                                                                                    Bio-Rad                         1721019; AB_11125143         WB 1:10000

  Antibody                                                 anti-myc (monoclonal mouse)                                                                                                       Invitrogen                      132500                       WB 1:2000

  Antibody                                                 anti-HA (monoclonal mouse)                                                                                                        Enzo Life Sciences AG           CO-MMS-101 R-1000            WB 1:5000

  Antibody                                                 anti-EF1a (monoclonal mouse)                                                                                                      Merck Millipore                 05--235                      WB 1:10000

  Antibody                                                 anti-ATOM40 (polyclonal rabbit)                                                                                                   N/A                                                          WB 1:10000, IF 1:1000

  Antibody                                                 anti-CytC (polyclonal rabbit)                                                                                                     N/A                                                          WB 1:1000

  Antibody                                                 anti-ATOM69 (polyclonal rabbit, affinity purified)                                                                                N/A                                                          WB 1:50

  Antibody                                                 anti-TbTim9 (polyclonal rabbit)                                                                                                   N/A                                                          WB 1:20

  Antibody                                                 anti-mtHsp70 (mouse)                                                                                                              N/A                                                          WB 1:1000

  Antibody                                                 anti-ATOM46 (polyclonal rabbit; affinity purified)                                                                                N/A                                                          WB 1:50

  Antibody                                                 anti-ATOM19 (mouse)                                                                                                               N/A                                                          WB 1:500

  Antibody                                                 anti-ATOM14 (polyclonal rabbit)                                                                                                   N/A                                                          WB 1:500

  Antibody                                                 anti-pATOM36 (polyclonal rabbit; affintiy purified)                                                                               N/A                                                          WB 1:250

  Antibody                                                 anti-rabbit Alexa488                                                                                                              ThermoFisher Scientific                                      IF 1:1000

  Antibody                                                 anti-rabbit IRDye 800CW                                                                                                           LI-COR Biosciences              P/N 925--32211               WB 1:20000

  Antibody                                                 anti-mouse IRDye LT680                                                                                                            LI-COR Biosciences              P/N 925--68020; AB_2687826   WB 1:20000

  Antibody                                                 anti-mouse (HRP-coupled goat)                                                                                                     Sigma Aldrich                   AP308P                       WB 1:5000

  Antibody                                                 anti-rabbit (HRP coupled goat)                                                                                                    Sigma Aldrich                   AP307P                       WB 1:5000

  Recombinant DNA reagent                                  Ø; pYX142 (plasmid)                                                                                                                                                                            

  Recombinant DNA reagent                                  pATOM36; pYX142-pATOM36 (plasmid)                                                                                                 this paper                                                   pATOM36 ORF was amplified from pFT33 and cloned in pYX142 between EcoRI and BamHI

  Recombinant DNA reagent                                  pATOM36-HA; pYX142-pATOM36-3HA (plasmid)                                                                                          this paper                                                   pATOM36 ORF was amplified from pFT33 and cloned in pYX142 between EcoRI and BamHI

  Recombinant DNA reagent                                  ^35^S-Mim1; pGEM4-Mim1-4M (plasmid)                                                                                               DOI: 10.1038/sj.embor.7400318                                

  Recombinant DNA reagent                                  ^35^S-pATOM36; pGEM4-pATOM36 (plasmid)                                                                                            this paper                                                   pATOM36 ORF was subcloned from pYX142-pATOM36 in pGEM4 with EcoRI and BamHI

  Recombinant DNA reagent                                  ^35^S-Tom20~ext~; pGEM4-Tom20~ext~ (plasmid)                                                                                      DOI: 10.1074/jbc.M410905200                                  

  Recombinant DNA reagent                                  ^35^S-Tom20; pGEM3-Tom20 (plasmid)                                                                                                DOI: 10.1074/jbc.M410905200                                  

  Recombinant DNA reagent                                  ^35^S-Ugo1; pGEM4-Ugo1 (plasmid)                                                                                                  DOI: 10.1083/jcb.201102041                                   

  Recombinant DNA reagent                                  ^35^S-Fis1; pGEM4-Fis1-TMC (plasmid)                                                                                              DOI:10.1242/jcs.024034                                       

  Recombinant DNA reagent                                  ^35^S-pSu9-DHFR; pGEM4-pSu9-DHFR (plasmid)                                                                                        PMID: 2892669                                                

  Recombinant DNA reagent                                  mito-GFP; pRS426-TPI-pSu9-eGFP (plasmid)                                                                                          this paper                                                   pSu9-eGFP was subcloned from pYX142-pSu9-GFP (Westermann B. and Neupert W. *Yeast*, 2000) to pRS426 with EcoRI and HindIII

  Peptide, recombinant protein GST                         GST                                                                                                                               DOI:10.1128/MCB.00227--13                                    

  Peptide, recombinant protein GST-Tom70                   GST-Tom70                                                                                                                         DOI:10.1128/MCB.00227--13                                    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Yeast strains and growth conditions {#s4-1}
-----------------------------------

Yeast strains used in the study were isogenic to *Saccharomyces cerevisiae* strain W303α beside *mas37Δ,* which is isogenic to YPH499. Standard genetic techniques were used for growth and manipulation of yeast strains. Yeast cells were grown in synthetic medium S (0.67% \[w/v\] bacto-yeast nitrogen base without amino acids) with glucose (2% \[w/v\]), glycerol (3% \[w/v\]), or lactate (2% \[w/v\]) as carbon source. Transformation of yeast cells was performed by the lithium acetate method. Strains deleted for *MIM1*, *MIM2* or both were previously described ([@bib10]). For drop-dilution assay, cells were grown in a synthetic medium to an OD~600~ of 1.0 and diluted in fivefold increments followed by spotting 5 μl of the diluted cells on solid media.

Transgenic cell lines and growth of *T. brucei* {#s4-2}
-----------------------------------------------

Transgenic procyclic cell lines are based on *T. brucei* 29--13 cells ([@bib40]) and were grown at 27°C in SDM-79 medium supplemented with 10% FCS (v/v). The RNAi cell line targeting the open reading frame of pATOM36 (Tb927.7.5700, Q582I5) was previously described ([@bib32]). For growth curves, tetracycline induced and uninduced cell lines were diluted to 2 × 10^6^ cells/ml every 2 days and the cumulative cell number was calculated.

Recombinant DNA techniques {#s4-3}
--------------------------

pATOM36 and its 3xHA-tagged variant were cloned into the yeast expression plasmid pYX142-TPI*~pro~* using the EcoRI and BamHI cutting sites. For simultaneous and inducible expression of *S.c.* Mim1-myc and Mim2-HA in *T. brucei,* the appropriate cell line was transfected with a pLew100-based plasmid ([@bib5]; [@bib40]). For optimal expression of the proteins, the ORFs were adapted to the codon usage of *T. brucei* according to [@bib16]). The intergenic region of the α- and β-tubulin genes was cloned in between the ORFs. The insert was synthesised by GenScript with flanking HindIII and BamHI sites for cloning into the pLew100 vector.

For expression from distinct plasmids, the ORFs of *MIM1* and *MIM2* were amplified from yeast genomic DNA and cloned into pLew100-based expression vectors using HindIII and BamHI for *MIM1* and HindIII and XbaI for *MIM2*.

Biochemical methods {#s4-4}
-------------------

Protein samples for immunodecoration were analysed on 8, 12, 12.5, or 15% SDS-PAGE and subsequently transferred onto nitrocellulose membranes by semi-dry western blotting. Proteins were detected by incubating the membranes first with primary antibodies and then with either horseradish peroxidase-conjugates of goat anti-rabbit, goat anti-mouse or goat anti-rat secondary antibodies or with secondary antibodies coupled to fluorescent dye and usage of the LI-COR system.

Isolation of mitochondria from yeast cells was performed by differential centrifugation, as previously described ([@bib9]). For protease protection assay, 50 µg of mitochondria were resuspended in 100 µl of SEM buffer (250 mM sucrose, 1 mM EDTA, 10 mM MOPS, pH 7.2). As a control, mitochondria were treated with 1% Triton X-100 in SEM buffer and incubated on ice for 30 min. The samples were supplemented with Proteinase K (50 µg/ml) and incubated on ice for 30 min. The proteolytic reaction was stopped with 5 mM Phenylmethylsulfonyl fluoride (PMSF). The samples were precipitated with trichloroacetic acid (TCA) and resuspended in 40 µl of 2x Laemmli buffer, heated for 10 min at 95°C, and analysed by SDS-PAGE and immunoblotting.

To analyse the membrane topology of proteins, alkaline extraction was performed. Mitochondria (50 µg) were resuspended in 100 µl of buffer containing 10 mM HEPES-KOH, 100 mM Na~2~CO~3~, pH 11.5 and incubated 30 min on ice. The membrane fraction was pelleted by centrifugation (76000xg, 30 min, 2°C) and the supernatant fraction was precipitated with TCA. Both fractions were resuspended in 40 µl of 2x Laemmli buffer, heated for 10 min at 95°C, and analysed by SDS-PAGE and immunoblotting.

GST-pulldown with radiolabelled proteins was performed as previously described ([@bib29]).

For mitochondria enriched fractions by digitonin extraction of *T. brucei,* the cells were incubated for 10 min on ice in 20 mM Tris-HCl pH 7.5, 0.6 M sorbitol, 2 mM EDTA containing 0.025% (w/v) digitonin. After centrifugation (6,800 g, 4°C), the resulting mitochondria enriched fraction was separated from the supernatant and subjected to SDS-PAGE. The mitochondria enriched pellets were also used for further experiments.

In vitro synthesis and mitochondrial import of radiolabelled proteins {#s4-5}
---------------------------------------------------------------------

In vitro transcription was performed with SP6 polymerase from either pGEM4 or pGEM3 plasmid encoding the gene of interest. Proteins were then in vitro translated from the acquired mRNA in the presence of ^35^S-methionine in rabbit reticulocyte lysate (Promega, Madison, WI, USA). Protein import was performed by adding 50 µg of isolated organelles to 100 µl of import buffer harboring 1 mM NADH and 2 mM ATP. Then, the translation reaction was added to the mitochondria solution and import of precursor proteins was performed at either 25°C for pSu9-DHFR, Tom20 and Ugo1 or at 2°C for Fis1 and Tom20~ext~. Import of Tom20, Fis1-TMC, and Ugo1 was monitored according to established assays ([@bib1]; [@bib20]; [@bib28]).

Blue native gel electrophoresis (BN-PAGE) {#s4-6}
-----------------------------------------

Assembly of native complexes was analysed by BN-PAGE. Mitochondria or mitochondria-enriched fractions were solubilised with buffer (1% digitonin or 0.2% TritonX-100, 20 mM Tris, 0.1 mM EDTA, 50 mM NaCl, 10% glycerol, pH 7.4) for 30 min at 4°C on an overhead shaker. After a clarifying spin (30,000xg, 15 min, 2°C), 10x sample buffer (5% \[wt/vol\] Coomassie brilliant blue G-250, 100 mM Bis-Tris, 500 mM 6-aminocaproic acid, pH 7.0) was added and the mixture was analysed by electrophoresis in a blue native gel containing either 6--14% or 8--13% gradient of acrylamide ([@bib33]). To analyse the assembly of radiolabelled Tom20 molecules, the organelles were solubilised with 0.2% digitonin. BN-PAGE was followed by either western blotting or autoradiography. The mixture NativeMark Unstained Protein Standard was used to monitor the migration of molecular weight marker proteins.

Fluorescence microscopy {#s4-7}
-----------------------

Fluorescence images of yeast cells were acquired with spinning disk microscope Zeiss Axio Examiner Z1 equipped with a CSU-X1 real-time confocal system (Visitron, Puchheim, Germany), VS-Laser system, and SPOT Flex CCD camera (Visitron Systems). Images were analysed with VisiView software (Visitron). Immunofluorescence images of *T. brucei* were acquired with a DFC360 FX monochrome camera (Leica Microsystrems, Nussloch, Germany) and a DMI6000B microscope (Leica Microsystems). Image analysis was done using LAS X software (Leica Microsystems), ImageJ, and Adobe Photoshop CS5.1 (Adobe).
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Thank you for submitting your article \"Independent evolution of functionally exchangeable mitochondrial outer membrane import complexes\" for consideration by *eLife*. Your article has been favorably evaluated by Vivek Malhotra (Senior Editor) and three reviewers, one of whom, Nikolaus Pfanner, is a member of our Board of Reviewing Editors. The following individual involved in review of your submission has agreed to reveal his identity: Kostas Tokatlidis (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Mitochondria are iconic structures of eukarytotic cells and are involved in many important functions including oxidative phosphorylation. The greater part of the mitochondrial proteome derives from nuclear-encoded proteins, which are synthesized in the cytosol and subsequently imported into mitochondria. The MIM pathway (consisting of the two outer membrane proteins Mim1/Mim2) is a fungal specific-pathway required for the biogenesis of a subset of outer membrane proteins, including subunits of the general entry gate of the organelle the TOM complex. pATOM36 is a recently identified trypanosomatid-specific essential mitochondrial outer membrane protein that functions in the biogenesis of outer membrane proteins and transmission of mitochondrial DNA. In this study Vitali and colleagues show that Mim1/Mim2 and pATOM36 are functionally interchangeable by using complementation analysis in yeast and *T. brucei* together with functional analyses of import defects.

The study is important as no functional homologs of the fungal Mim1/2 system have yet been identified in any other eukaryotes. Remarkably, pATOM36 and Mim1/2 share no sequence homology and are different in their topology and possibly structure. The results reveal that MIM and pATOM36 are the products of convergent evolution, which arose after the ancestors of fungi and trypanosomes diverged.

The work presented in this manuscript is thorough and explores a crucial question of mitochondrial biology, representing the first case of convergent evolution for the mitochondrial protein import machinery.

Essential revisions:

1\) The authors present a number of data indicating that pATOM36 may compensate for the loss of the MIM machinery but do not directly show a role of pATOM36 in protein import into the outer membrane of yeast mitochondria. The authors should perform in vitro import assays into isolated yeast mitochondria to show that the import of MIM substrates, including specific TOM subunits, is restored upon expression of pATOM36 in MIM mutant strains. Are MIM-independent protein import pathways impaired in the MIM double mutant and are they affected by expression of pATOM36?

Figure 3A: The levels of Ugo1 and Tom70 are not completely restored upon expression of pATOM36, when compared to the levels of Tom20. A quantification of these Western blots will be helpful. It would be valuable to see how the in vitro import and assembly of these substrates is influenced in these cells, as it might reveal that pATOM36 might have a preference for certain MIM substrates.

2\) Given that the protein biogenesis function of pATOM36 is substantially restored one wonders whether only MIm1 could do this in trypanosomes or whether there is an additive effect of MIm1 and Mim2 in these studies.

Why does expression of Mim1/Mim2 not complement the loss of kDNA? Does this have something to do with the considerably larger size/topology of pATOM36? Does this imply that only the TMDs of pATOM36 are involved in the biogenesis of outer membrane proteins?

3\) Does pATOM36 expressed in yeast cooperate with Tom70, as has been shown for Mim1?

4\) Many of the BN blots (for instance Figure 3C) are saturated and need be shown as lower-exposures.

10.7554/eLife.34488.019

Author response

> Essential revisions:
>
> 1\) The authors present a number of data indicating that pATOM36 may compensate for the loss of the MIM machinery but do not directly show a role of pATOM36 in protein import into the outer membrane of yeast mitochondria. The authors should perform in vitro import assays into isolated yeast mitochondria to show that the import of MIM substrates, including specific TOM subunits, is restored upon expression of pATOM36 in MIM mutant strains. Are MIM-independent protein import pathways impaired in the MIM double mutant and are they affected by expression of pATOM36?

As was proposed, we performed in vitro import assays of radiolabeled MIM substrates like Ugo1 and Tom20. We did not test Tom70 import as we are not aware of a specific and reliable in vitro assay to monitor the correct membrane integration of this protein. In agreement with the changes in the steady state levels (see below), the expression of pATOM36 did not result in a significant effect on the extent of import of Ugo1 but improved significantly the import of Tom20 in the mim1Δ/mim2Δ double deletion strain. The presence of pATOM36 did not affect the import of control non MIM substrates like pSu9-DHFR or Fis1. These new findings are included in revised Figure 4 and are described and discussed in the revised Results and Discussion sections.

> Figure 3A: The levels of Ugo1 and Tom70 are not completely restored upon expression of pATOM36, when compared to the levels of Tom20. A quantification of these Western blots will be helpful. It would be valuable to see how the in vitro import and assembly of these substrates is influenced in these cells, as it might reveal that pATOM36 might have a preference for certain MIM substrates.

We followed the suggestion of the reviewers and quantified the immunodecorations of the MIM substrates. Indeed, the effect of pATOM36 on such substrates is variable (revised Figure 3B). Whereas, the expression of pATOM36 in the mim1Δ/mim2Δ double deletion strain elevated significantly the levels of Tom70 and especially of Tom20, those of Ugo1 were only mildly increased. Hence, considering also the in vitro import assays (see above), it seems that pATOM36 has a preference for certain MIM substrates like Tom20. These new findings are described and discussed in the revised Results and Discussion sections.

> 2\) Given that the protein biogenesis function of pATOM36 is substantially restored one wonders whether only MIm1 could do this in trypanosomes or whether there is an additive effect of MIm1 and Mim2 in these studies.

We could identify clones of pATOM36-RNAi cell lines, which unintentionally express only tagged Mim1 or Mim2 in major amounts and in which the other partner protein was barely detected. In such clones, we could neither detect rescue of growth retardation nor restoration of the ATOM assembly defect. Thus, we conclude that restoration of the ATOM complex biogenesis defect requires both MIM subunits. These new results are shown in the newly added supplementary Figure 8---figure supplement 1 of the revised manuscript and are discussed at the end of the Results section (new section entitled \"Complementing the biogenesis function of pATOM36 requires Mim1 and Mim2\"). In addition, relevant information was added to the Materials and methods" section.

> Why does expression of Mim1/Mim2 not complement the loss of kDNA? Does this have something to do with the considerably larger size/topology of pATOM36?

It has previously been shown that pATOM36 is present in three distinct complexes of approximately 140, 250 and 480 kDa (Käser et al., 2016). Based on the present study, the 140 and 250 kDa complexes likely represent homo-oligomers of pATOM36. Co-immunoprecipitations of tagged pATOM36 with *T. brucei* cells identified a number of interacting proteins of the 480 kDa complex. Many of these are subunits of the tripartite attachment complex (TAC), which links the kDNA to the basal body of the flagellum and is essential for kDNA maintenance. The TAC is a multiprotein complex of which presently seven subunits were characterized. Each of these subunits is specific for trypanosomatids and essential for TAC function. Thus, pATOM36 needs to interact with other TAC subunits in order to function in the TAC, whereas it does not require other proteins to perform its role in outer membrane protein biogenesis. Our findings that expression of Mim1 and Mim2 selectively complements the outer membrane protein biogenesis but not the mitochondrial DNA inheritance phenotype is therefore expected. It would indeed be very surprising if Mim1 and Mim2 would interact with trypanosomatid-specific TAC subunits.

> Does this imply that only the TMDs of pATOM36 are involved in the biogenesis of outer membrane proteins?

This is a complex question since, as stated in the manuscript, we do not know how many transmembrane domains pATOM36 really has. However, it is known that pATOM36 contains domains specialized for only one of its two functions. Previous complementation experiments have shown that the C-terminal 75 amino acids, which contain the transmembrane domain, which is predicted with the highest score, are dispensable for mitochondrial DNA inheritance but are required for the biogenesis of the ATOM complex (Käser et al., 2016).

In order to test further this point, we aimed to expressed in yeast cells the pATOM36 variant that lacks the 75 C-terminally amino acids. Unfortunately, this variant was detected in very low levels, suggesting that it is unstable in the yeast environment. Therefore, its inability to complement the mim1Δ/mim2Δ growth defect cannot be interpreted.

> 3\) Does pATOM36 expressed in yeast cooperate with Tom70, as has been shown for Mim1?

We performed several experiments in order to address this point. Initially, we solubilized mitochondria from yeast cells expressing pATOM36-HA and tested whether Tom70 can be pulled-down by the former protein. We could not observe any specific binding, probably because the interaction under physiological conditions is transient. It should be noted that His tagged-Tom70 could pull-down only minor amounts of Mim1 (\<0.5% of total Mim1) in digitonin-solubilized mitochondria (Becker et al., 2011).

Next, to test the potential of the two proteins to interact with each other, we used recombinant GST-Tom70 cytosolic domain (and GST alone as control) and incubated them with in vitro synthesized radiolabeled Mim1 or pATOM36. We detected specific interaction of Tom70 with both proteins. Thus, although this outcome is not an evidence for an in vivo interaction, it demonstrates that pATOM36 and Tom70 can interact with each other. Naturally, we cannot exclude the possibility that Tom70 recognizes either Mim1 or pATOM36 as substrates rather than as interaction partners. These new results are included in revised Figure 3E and are described in the revised Results sections.

> 4\) Many of the BN blots (for instance Figure 3C) are saturated and need be shown as lower-exposures.

We corrected this point and the BN-PAGE immunodecorations in revised Figures 1B, 3D, and Figure 3---figure supplement 1A are shown with lower exposures.

[^1]: These authors contributed equally to this work.
